Login / Signup

Tolvaptan therapy for edema in patients with chronic kidney disease.

Li ZhouQianqian XuXuehua XiXueying YuWenge Li
Published in: Clinical nephrology (2024)
As long as a rational treatment regimen is followed, tolvaptan is a safe and effective diuretic for treating edema in CKD, even in the late stages of CKD without reducing residual renal function in the patients.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • acute heart failure
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • peritoneal dialysis
  • heart failure
  • patient reported outcomes
  • atrial fibrillation